Transcription factor LSF (TFCP2) inhibits melanoma growth

Yuji Goto, Ichiro Yajima, Mayuko Kumasaka, Nobutaka Ohgami, Asami Tanaka, Toyonori Tsuzuki, Yuji Inoue, Satoshi Fukushima, Hironobu Ihn, Mikiko Kyoya, Hiroyuki Ohashi, Tamihiro Kawakami, Dorothy C. Bennett, Masashi Kato

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent growth of melanoma cells was suppressed by LSF overexpression through an increased percentage of G1 phase cells and an increased p21CIP1 expression level in vitro and in vivo. Anchorage-dependent growth in LSF-overexpressed melanoma cells was promoted by depletion of LSF in the LSF-overexpressed cells. Integrated results of our EMSA and chromatin immunoprecipitation assays showed binding of LSF within a 150-bp upstream region of the transcription start site of p21CIP1 in melanoma cells. Taken together, our results suggest potential roles of LSF as a growth regulator through control of the transcription of p21CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus.

Original languageEnglish
Pages (from-to)2379-2390
Number of pages12
JournalOncotarget
Volume7
Issue number3
DOIs
Publication statusPublished - 2016 Jan 1
Externally publishedYes

Keywords

  • CDKN1A
  • Cell cycle
  • Melanoma
  • TFCP2
  • Transcription factor LSF

ASJC Scopus subject areas

  • Oncology

Cite this

Goto, Y., Yajima, I., Kumasaka, M., Ohgami, N., Tanaka, A., Tsuzuki, T., ... Kato, M. (2016). Transcription factor LSF (TFCP2) inhibits melanoma growth. Oncotarget, 7(3), 2379-2390. https://doi.org/10.18632/oncotarget.6230

Transcription factor LSF (TFCP2) inhibits melanoma growth. / Goto, Yuji; Yajima, Ichiro; Kumasaka, Mayuko; Ohgami, Nobutaka; Tanaka, Asami; Tsuzuki, Toyonori; Inoue, Yuji; Fukushima, Satoshi; Ihn, Hironobu; Kyoya, Mikiko; Ohashi, Hiroyuki; Kawakami, Tamihiro; Bennett, Dorothy C.; Kato, Masashi.

In: Oncotarget, Vol. 7, No. 3, 01.01.2016, p. 2379-2390.

Research output: Contribution to journalArticle

Goto, Y, Yajima, I, Kumasaka, M, Ohgami, N, Tanaka, A, Tsuzuki, T, Inoue, Y, Fukushima, S, Ihn, H, Kyoya, M, Ohashi, H, Kawakami, T, Bennett, DC & Kato, M 2016, 'Transcription factor LSF (TFCP2) inhibits melanoma growth', Oncotarget, vol. 7, no. 3, pp. 2379-2390. https://doi.org/10.18632/oncotarget.6230
Goto Y, Yajima I, Kumasaka M, Ohgami N, Tanaka A, Tsuzuki T et al. Transcription factor LSF (TFCP2) inhibits melanoma growth. Oncotarget. 2016 Jan 1;7(3):2379-2390. https://doi.org/10.18632/oncotarget.6230
Goto, Yuji ; Yajima, Ichiro ; Kumasaka, Mayuko ; Ohgami, Nobutaka ; Tanaka, Asami ; Tsuzuki, Toyonori ; Inoue, Yuji ; Fukushima, Satoshi ; Ihn, Hironobu ; Kyoya, Mikiko ; Ohashi, Hiroyuki ; Kawakami, Tamihiro ; Bennett, Dorothy C. ; Kato, Masashi. / Transcription factor LSF (TFCP2) inhibits melanoma growth. In: Oncotarget. 2016 ; Vol. 7, No. 3. pp. 2379-2390.
@article{80e7f25e63354454ba43171cf7a8c5f9,
title = "Transcription factor LSF (TFCP2) inhibits melanoma growth",
abstract = "Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent growth of melanoma cells was suppressed by LSF overexpression through an increased percentage of G1 phase cells and an increased p21CIP1 expression level in vitro and in vivo. Anchorage-dependent growth in LSF-overexpressed melanoma cells was promoted by depletion of LSF in the LSF-overexpressed cells. Integrated results of our EMSA and chromatin immunoprecipitation assays showed binding of LSF within a 150-bp upstream region of the transcription start site of p21CIP1 in melanoma cells. Taken together, our results suggest potential roles of LSF as a growth regulator through control of the transcription of p21CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus.",
keywords = "CDKN1A, Cell cycle, Melanoma, TFCP2, Transcription factor LSF",
author = "Yuji Goto and Ichiro Yajima and Mayuko Kumasaka and Nobutaka Ohgami and Asami Tanaka and Toyonori Tsuzuki and Yuji Inoue and Satoshi Fukushima and Hironobu Ihn and Mikiko Kyoya and Hiroyuki Ohashi and Tamihiro Kawakami and Bennett, {Dorothy C.} and Masashi Kato",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.6230",
language = "English",
volume = "7",
pages = "2379--2390",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "3",

}

TY - JOUR

T1 - Transcription factor LSF (TFCP2) inhibits melanoma growth

AU - Goto, Yuji

AU - Yajima, Ichiro

AU - Kumasaka, Mayuko

AU - Ohgami, Nobutaka

AU - Tanaka, Asami

AU - Tsuzuki, Toyonori

AU - Inoue, Yuji

AU - Fukushima, Satoshi

AU - Ihn, Hironobu

AU - Kyoya, Mikiko

AU - Ohashi, Hiroyuki

AU - Kawakami, Tamihiro

AU - Bennett, Dorothy C.

AU - Kato, Masashi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent growth of melanoma cells was suppressed by LSF overexpression through an increased percentage of G1 phase cells and an increased p21CIP1 expression level in vitro and in vivo. Anchorage-dependent growth in LSF-overexpressed melanoma cells was promoted by depletion of LSF in the LSF-overexpressed cells. Integrated results of our EMSA and chromatin immunoprecipitation assays showed binding of LSF within a 150-bp upstream region of the transcription start site of p21CIP1 in melanoma cells. Taken together, our results suggest potential roles of LSF as a growth regulator through control of the transcription of p21CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus.

AB - Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent growth of melanoma cells was suppressed by LSF overexpression through an increased percentage of G1 phase cells and an increased p21CIP1 expression level in vitro and in vivo. Anchorage-dependent growth in LSF-overexpressed melanoma cells was promoted by depletion of LSF in the LSF-overexpressed cells. Integrated results of our EMSA and chromatin immunoprecipitation assays showed binding of LSF within a 150-bp upstream region of the transcription start site of p21CIP1 in melanoma cells. Taken together, our results suggest potential roles of LSF as a growth regulator through control of the transcription of p21CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus.

KW - CDKN1A

KW - Cell cycle

KW - Melanoma

KW - TFCP2

KW - Transcription factor LSF

UR - http://www.scopus.com/inward/record.url?scp=84962311311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962311311&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.6230

DO - 10.18632/oncotarget.6230

M3 - Article

C2 - 26506241

AN - SCOPUS:84962311311

VL - 7

SP - 2379

EP - 2390

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 3

ER -